CD86 and type 1 diabetes mellitus: In addition, CD5+ B cells in T1D, Ab+, and ND subjects had comparable surface expression of CD86 and CD40, confirming that the detected changes in IL-10 and FasL expression by these cells was specific and not due to generalized modulation of their surface profile (Figure S5 in Supplementary Material).